Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 276

1.

Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.

Ringdén O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lönnies H, Marschall HU, Dlugosz A, Szakos A, Hassan Z, Omazic B, Aschan J, Barkholt L, Le Blanc K.

Transplantation. 2006 May 27;81(10):1390-7.

PMID:
16732175
2.

Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease.

Fang B, Song Y, Liao L, Zhang Y, Zhao RC.

Transplant Proc. 2007 Dec;39(10):3358-62.

PMID:
18089385
3.

Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium.

von Bonin M, Stölzel F, Goedecke A, Richter K, Wuschek N, Hölig K, Platzbecker U, Illmer T, Schaich M, Schetelig J, Kiani A, Ordemann R, Ehninger G, Schmitz M, Bornhäuser M.

Bone Marrow Transplant. 2009 Feb;43(3):245-51. doi: 10.1038/bmt.2008.316. Epub 2008 Sep 29.

PMID:
18820709
4.

Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.

Gonzalo-Daganzo R, Regidor C, Martín-Donaire T, Rico MA, Bautista G, Krsnik I, Forés R, Ojeda E, Sanjuán I, García-Marco JA, Navarro B, Gil S, Sánchez R, Panadero N, Gutiérrez Y, García-Berciano M, Pérez N, Millán I, Cabrera R, Fernández MN.

Cytotherapy. 2009;11(3):278-88. doi: 10.1080/14653240902807018.

PMID:
19308773
5.

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.

Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR Jr, Moseley AB, Bacigalupo A.

Biol Blood Marrow Transplant. 2005 May;11(5):389-98.

6.

Single intra-arterial injection of mesenchymal stromal cells for treatment of steroid-refractory acute graft-versus-host disease: a pilot study.

Arima N, Nakamura F, Fukunaga A, Hirata H, Machida H, Kouno S, Ohgushi H.

Cytotherapy. 2010 Apr;12(2):265-8. doi: 10.3109/14653240903390795.

PMID:
19961282
7.

Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study.

Greinix HT, Volc-Platzer B, Kalhs P, Fischer G, Rosenmayr A, Keil F, Hönigsmann H, Knobler RM.

Blood. 2000 Oct 1;96(7):2426-31.

8.

Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.

Müller I, Kordowich S, Holzwarth C, Isensee G, Lang P, Neunhoeffer F, Dominici M, Greil J, Handgretinger R.

Blood Cells Mol Dis. 2008 Jan-Feb;40(1):25-32. Epub 2007 Sep 14.

PMID:
17869550
9.

Inolimomab in steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: retrospective analysis and comparison with other interleukin-2 receptor antibodies.

Bay JO, Dhédin N, Goerner M, Vannier JP, Marie-Cardine A, Stamatoullas A, Jouet JP, Yakoub-Agha I, Tabrizi R, Faucher C, Diez-Martin JL, Nunez G, Parody R, Milpied N, Espérou H, Garban F, Galambrun C, Kwiatkovski F, Darlavoix I, Zinaï A, Fischer A, Michallet M, Vernant JP.

Transplantation. 2005 Sep 27;80(6):782-8.

PMID:
16210965
10.

Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody.

Kobbe G, Schneider P, Rohr U, Fenk R, Neumann F, Aivado M, Dietze L, Kronenwett R, Hünerlitürkoglu A, Haas R.

Bone Marrow Transplant. 2001 Jul;28(1):47-9.

11.

Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease.

Hervé P, Flesch M, Tiberghien P, Wijdenes J, Racadot E, Bordigoni P, Plouvier E, Stephan JL, Bourdeau H, Holler E, et al.

Blood. 1992 Jun 15;79(12):3362-8.

12.

Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population.

Lucchini G, Introna M, Dander E, Rovelli A, Balduzzi A, Bonanomi S, Salvadè A, Capelli C, Belotti D, Gaipa G, Perseghin P, Vinci P, Lanino E, Chiusolo P, Orofino MG, Marktel S, Golay J, Rambaldi A, Biondi A, D'Amico G, Biagi E.

Biol Blood Marrow Transplant. 2010 Sep;16(9):1293-301. doi: 10.1016/j.bbmt.2010.03.017. Epub 2010 Mar 27.

13.

Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats.

Aksu AE, Horibe E, Sacks J, Ikeguchi R, Breitinger J, Scozio M, Unadkat J, Feili-Hariri M.

Clin Immunol. 2008 Jun;127(3):348-58. doi: 10.1016/j.clim.2008.02.003. Epub 2008 Apr 2.

PMID:
18387852
14.

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringdén O; Developmental Committee of the European Group for Blood and Marrow Transplantation.

Lancet. 2008 May 10;371(9624):1579-86. doi: 10.1016/S0140-6736(08)60690-X.

PMID:
18468541
15.

Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner.

Joo SY, Cho KA, Jung YJ, Kim HS, Park SY, Choi YB, Hong KM, Woo SY, Seoh JY, Cho SJ, Ryu KH.

Cytotherapy. 2010 May;12(3):361-70. doi: 10.3109/14653240903502712.

PMID:
20078382
17.

[Mesenchymal stem cells for treatment of steroid-resistant chronic graft-versus-host disease].

Zhang LS, Liu QF, Huang K, Zhang Y, Fan ZP, Huang SL.

Zhonghua Nei Ke Za Zhi. 2009 Jul;48(7):542-6. Chinese.

PMID:
19957792
18.

Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.

Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC.

Biol Blood Marrow Transplant. 2009 Jun;15(6):704-17. doi: 10.1016/j.bbmt.2009.02.010. Epub 2009 Apr 9.

19.

Infliximab for the treatment of severe steroid refractory acute graft-versus-host disease in three patients after allogeneic hematopoietic transplantation.

Yamane T, Yamamura R, Aoyama Y, Nakamae H, Hasegawa T, Sakamoto C, Shibata H, Terada Y, Koh G, Hino M.

Leuk Lymphoma. 2003 Dec;44(12):2095-7.

PMID:
14959853
20.

Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin.

Remberger M, Aschan J, Barkholt L, Tollemar J, Ringdén O.

Clin Transplant. 2001 Jun;15(3):147-53. Review.

PMID:
11389703

Supplemental Content

Support Center